Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this 6 month open-label extension trial is to evaluate long-term safety and tolerability of dalteparin in treatment of chronic neuroischaemic foot ulcers in diabetic patients with peripheral arteria? occlusive disease (PAOD) and peripheral neuropathy.
Critère d'inclusion
- Diabetic Foot Ulcer